The current focus is on the development, production, and distribution of drugs, particularly for radiology, neurology, and oncology. Especially in the area of contract manufacturing of specialties, the company plans to offer itself to large pharmaceutical companies as a European ‘second source’ for the production of specialty active ingredients. On-site partnerships with local B2B partners ensure adequate market access in over 35 countries, and international expansion is to be further intensified. A solid basis for future developments is provided by many years of experience as a manufacturer of contrast agents for diagnostic imaging and active ingredients.

As a reliable intermediary between industry, trade and end customers, the Group provides an innovative and broad product portfolio for the European market – from its own production in the field of horse feed and nutrition supplements to “white label” contract production and almost all important retail brands. The in-house product portfolio of more than 4,000 products and the services offered are constantly being expanded. Modern production facilities, experience in brand development paired with sales competence as well as complementary organizational structures make comprehensive potential evident.

With an all-in concept, innovative products can be manufactured as part of contract manufacturing or entire ranges can be taken to market maturity. Private label customers benefit from a comprehensive range of animal feed, specialties and care products – for horses, dogs, cats and rodents. Downstream logistics offerings allow maximum flexibility. At the same time, new cooperative ventures with renowned innovative manufacturers in the industry are being driven forward.